Josephh Capper News Today

30.04.2024 - Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management to Host Conference Call Today, April 30, 2024, ...

Receipt of FDA Warning Letter for AXIOFILL Classification; Not Related to Safety Request for Designation for AXIOFILL Submitted to FDA and Currently...

Operator: Good afternoon, and thank you for standing by. Welcome to the MiMedx Third Quarter ‘23 Operating and Financial Results Conference Call.

Company Raises Full-Year 2023 Net Sales Percentage Growth Outlook to High Teens

YAVNE, Israel, Aug. 15, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-gen...

MARIETTA, Ga., March 23, 2023 -- MiMedx Group, Inc. , a pioneer and leader in placental biologics, today announced that Peter M. Carlson, Chief Financial Officer, has decided to leave the Company... | March 23, 2023

11:44 AM Philips announced this past week that it will acquire BioTelemetry, a provider of remote cardiac diagnostics and monitoring, for $2.8 billion. The transaction is expected to be completed in the first quarter of 2021. The Pennsylvania-based BioTelemetry provides remote cardiac monitoring, centralized core laboratory services for clinical trials, remote blood glucose monitoring and original equipment manufacturing for healthcare and clinical research customers.  "The acquisition of BioT...

Philips acquires BioTelemetry for $2.8B Philips acquires BioTelemetry for $2.8B 18 December 2020 | News Source credit: Shutterstock Royal Philips and BioTelemetry Inc, a leading US-based provider of remote cardiac diagnostics and monitoring, have announced that they have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a tender offer to acquire all of the issued and outstanding shares of BioTelemetry for $72.00 per share, to be paid in cash upon com...

Royal Philips for $2.8 billion. Shares of BioTelemetry rose from Thursdays $61.78 closing price to as much as $73 on Friday, the stocks highest price in over a year. BioTelemetry is a Pennsylvania-based medical company that makes equipment that remotely diagnoses and monitors cardiac activity. . BioTelemetry gained as much as 18% on Friday after news that the cardiac-diagnostics firm will be acquired by Dutch company Royal Philips for $2.8 billion. BioTelemetry is a Pennsylvania-based medic...

Royal Philips: Philips to become a global leader in patient care management solutions for the hospital and the home through the acquisition of BioTelemetry, Inc. USD 72.00 per share; implied enterprise value of USD 2.8 billion (approx. EUR 2.3 billion) Acquisition is a strong fit with Philips strategy to transform the delivery of healthcare: combination of Philips leading patient monitoring position in the hospital with BioTelemetrys leading cardiac diagnostics and monitoring position outside t...